Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.58 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.54 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | CETP | P11597 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20397370 | 0.91 | ALDH1A1 (0.52) | PPARGGPR132EPHX2ALDH1A1KDM4E | |
| SCHEMBL8971701 | 0.91 | ALDH1A1 (0.52) | PPARGGPR132EPHX2ALDH1A1KDM4E | |
| SCHEMBL18045215 | 0.90 | PPARG (0.73) | PPARGGPR132FAAHMEN1KMT2A | |
| SCHEMBL677201 | 0.90 | PPARG (0.73) | PPARGGPR132FAAHMEN1KMT2A | |
| SCHEMBL31359284 | 0.90 | PPARG (0.73) | PPARGGPR132FAAHMEN1KMT2A | |
| SCHEMBL676737 | 0.90 | PPARG (0.73) | PPARGGPR132FAAHMEN1KMT2A | |
| SCHEMBL6288019 | 0.90 | PPARG (0.73) | PPARGGPR132FAAHMEN1KMT2A | |
| SCHEMBL677712 | 0.90 | PPARG (0.73) | PPARGGPR132FAAHMEN1KMT2A | |
| SCHEMBL8434207 | 0.88 | PPARG (0.58) | PPARGGPR132FAAHTHRBCETP | |
| SCHEMBL18907111 | 0.88 | EPHX2 (0.58) | EPHX2ALDH1A1TP53THRBCETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240002325-A1 | OXYLIPINS, PROCESSES FOR MAKING THE SAME, AND METHODS FOR USING THE SAME | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-01-04 | — | — | US | disclosed |
| WO-2022093755-A1 | OXYLIPINS, PROCESSES FOR MAKING THE SAME, AND METHODS FOR USING THE SAME | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2022-05-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002325-A1 | OXYLIPINS, PROCESSES FOR MAKING THE SAME, AND METHODS FOR USING THE SAME | LIPA, FADS1, FADS2 | PPARG 874/4885GPR132 4585/4885EPHX2 521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.